Rate of Prolonged Response After Stopping Thrombopoietin-receptor Agonists Treatment in ITP

NCT03119974 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Persistent or Chronic ITP

Interventions

DRUG: Tpo-RA discontinuation

Sponsor

Assistance Publique - Hôpitaux de Paris